Rapport Therapeutics, Inc. · NASDAQ:RAPP
Rapport Therapeutics, Inc. shareholders
As of Sep 30, 2026, 160 institutions reported holding Rapport Therapeutics, Inc., 84.9% of its shares. Largest: Fidelity, Trv Gp V, LLC and ARCH Venture Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Rapport Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 7.2M | 12.1% | +23,763 | Nov 10, 2026 |
| Trv Gp V, LLC | 6.28M | 10.6% | no change | Nov 16, 2026 |
| ARCH Venture Management, LLC | 3.73M | 6.3% | no change | Nov 16, 2026 |
| Capital Group | 3.21M | 5.4% | −268K | Nov 12, 2026 |
| Goldman Sachs | 2.97M | 5.0% | +63,347 | Nov 16, 2026 |
| BlackRock | 2.88M | 4.9% | +181K | Nov 13, 2026 |
| Cormorant Asset Management, LP | 2.46M | 4.1% | −200K | Nov 16, 2026 |
| Vanguard | 2.24M | 3.8% | +280K | Nov 13, 2026 |
| Sofinnova Investments, Inc. | 1.9M | 3.2% | no change | Nov 16, 2026 |
| Johnson & Johnson | 1.78M | 3.0% | no change | Oct 26, 2026 |